Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Glaxo Wellcome expands DNA vaccine program with PowderJect

March 28, 2000

Siga acquires Chlamydia vaccine technology from Oregon State University

March 27, 2000

Vasogen cleared to proceed with clinical trial of VAS-981 in leukemia patients

March 24, 2000

IND filed with FDA for ISAtx-247

March 23, 2000

Effects of TAK-603 on cytokine production reported at Japanese congress

March 22, 2000

Medinox's NO neutralizer prevents transplant rejection in preclinical study

March 21, 2000

Whole genome sequencing of N. meningitidis leads to novel vaccine candidates

March 20, 2000

SangStat files NDA in Canada for Thymoglobulin

March 17, 2000

Isotechnika receives Canadian approval for human testing of immunosuppressive drug

March 16, 2000

3M's new immunomodulators induce TNF-alpha, IFN-alpha biosynthesis, inhibit Th2 immune response

March 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...